Cours Chinook Tyee Industry Ltd Toronto S.E.
Actions
GBI.H
CA16961T2083
Produits pharmaceutiques
CA 2022 | - | CA 2023 | - | Capitalisation | 322 k 236 k 215 k |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -732 k -667 k | Résultat net 2023 | - 0 0 | VE / CA 2022 | - |
Dette nette 2022 | 3,15 M 2,31 M 2,1 M | Dette nette 2023 | 2,77 M 2,03 M 1,85 M | VE / CA 2023 | - |
PER 2022 |
-1,79
x | PER 2023 |
-1,08
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 74,11% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Investor Relations Contact | - | 01/01/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Frank Otto
BRD | Director/Board Member | - | 11/05/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+43,31% | 6,19 Md | |
-16,99% | 4,48 Md | |
+6,39% | 3,29 Md | |
-13,10% | 3,12 Md | |
-4,17% | 2,5 Md | |
+45,47% | 1,94 Md | |
-9,11% | 1,68 Md | |
-2,09% | 1,64 Md | |
-12,50% | 1,56 Md |